In Black South Africans from Rural and Urban Communities, the 4G/5G PAI-1 Polymorphism Influences PAI-1 Activity, but Not Plasma Clot Lysis Time

被引:6
|
作者
de Lange, Zelda [1 ]
Rijken, Dingeman C. [2 ]
Hoekstra, Tiny [1 ,3 ]
Conradie, Karin R. [1 ]
Jerling, Johann C. [1 ]
Pieters, Marlien [1 ]
机构
[1] North West Univ, Ctr Excellence Nutr, Potchefstroom, South Africa
[2] Erasmus Univ, Med Ctr, Dept Haematol, Rotterdam, Netherlands
[3] Leiden Univ, Med Ctr, Dept Clin Epidemiol, Leiden, Netherlands
来源
PLOS ONE | 2013年 / 8卷 / 12期
基金
英国医学研究理事会; 新加坡国家研究基金会;
关键词
PLASMINOGEN-ACTIVATOR INHIBITOR-1; MYOCARDIAL-INFARCTION; INSULIN-RESISTANCE; VENOUS THROMBOSIS; INCOME COUNTRIES; CORONARY ATHEROSCLEROSIS; CARDIOVASCULAR-DISEASE; CIRCULATING LEVELS; METABOLIC SYNDROME; ADIPOSE-TISSUE;
D O I
10.1371/journal.pone.0083151
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Data on genetic and environmental factors influencing PAI-1 levels and their consequent effect on clot lysis in black African populations are limited. We identified polymorphisms in the promoter area of the PAI-1 gene and determined their influence on PAI-1(act) levels and plasma clot lysis time (CLT). We also describe gene-environment interactions and the effect of urbanisation. Data from 2010 apparently healthy urban and rural black participants from the South African arm of the PURE study were cross-sectionally analysed. The 5G allele frequency of the 4G/5G polymorphism was 0.85. PAI-1(act) increased across genotypes in the urban subgroup (p = 0.009) but not significantly in the rural subgroup, while CLT did not differ across genotypes. Significant interaction terms were found between the 4G/5G polymorphism and BMI, waist circumference and triglycerides in determining PAI-1(act), and between the 4G/5G polymorphism and fibrinogen and fibrinogen gamma prime in determining CLT. The C428T and G429A polymorphisms did not show direct relationships with PAI-1(act) or CLT but they did influence the association of other environmental factors with PAI-1(act) and CLT. Several of these interactions differed significantly between rural and urban subgroups, particularly in individuals harbouring the mutant alleles. In conclusion, although the 4G/5G polymorphism significantly affected PAI-1(act), it contributed less than 1% to the PAI-1(act) variance. (Central) obesity was the biggest contributor to PAI-1(act) variance (12.5%). Urbanisation significantly influenced the effect of the 4G/5G polymorphism on PAI-1(act) as well as gene-environment interactions for the C428T and G429A genotypes in determining PAI-1(act) and CLT.
引用
收藏
页数:8
相关论文
共 50 条
  • [41] PAI-1-675 4G/5G Polymorphism in Association with Diabetes and Diabetic Complications Susceptibility: a Meta-Analysis Study
    Xu, Kuanfeng
    Liu, Xiaoyun
    Yang, Fan
    Cui, Dai
    Shi, Yun
    Shen, Chong
    Tang, Wei
    Yang, Tao
    PLOS ONE, 2013, 8 (11):
  • [42] A NEWBORN CASE OF INTESTINAL INFARCTION WITH HOMOZYGOUS MTHFR C677T AND HETEROZYGOUS OF FACTOR V LEIDEN G1691A, PAI-1 4G/5G MUTATIONS
    Sandal, G.
    Duman, L.
    Ayata, A.
    GENETIC COUNSELING, 2014, 25 (01): : 81 - 84
  • [43] The role of the t-PA I/D and PAI-1 4G/5G polymorphisms in African-American adults with a diagnosis of myocardial infarction or venous thromboembolism
    Hooper, WC
    Lally, C
    Austin, H
    Renshaw, M
    Dilley, A
    Wenger, NK
    Phillips, DJ
    Whitsett, C
    Rawlins, P
    Evatt, BL
    THROMBOSIS RESEARCH, 2000, 99 (03) : 223 - 230
  • [44] A-G-4G haplotype of PAI-1 gene polymorphisms-844 G/A, HindIII G/C, and-675 4G/5G is associated with increased risk of ischemic stroke caused by small vessel disease
    Adamski, M. G.
    Turaj, W.
    Slowik, A.
    Wloch-Kopec, D.
    Wolkow, P.
    Szczudlik, A.
    ACTA NEUROLOGICA SCANDINAVICA, 2009, 120 (02): : 94 - 100
  • [45] UNILATERAL RENAL VEIN THROMBOSIS IN A NEWBORN HETEROZYGOUS OF THE FACTOR II G20210A AND PAI-1 4G/15G GENE MUTATION
    Sandal, G.
    Kuybulu, A. E.
    Ayata, A.
    GENETIC COUNSELING, 2013, 24 (04): : 455 - 458
  • [46] Type 2 diabetes significantly modulates the cardiovascular risk conferred by the PAI-1-675 4G/5G polymorphism in angiographied coronary patients
    Saely, Christoph H.
    Muendlein, Axel
    Vonbank, Alexander
    Sonderegger, Gudrun
    Aczel, Stefan
    Rein, Philipp
    Risch, Lorenz
    Drexel, Heinz
    CLINICA CHIMICA ACTA, 2008, 396 (1-2) : 18 - 22
  • [47] Plasminogen activator inhibitor-1 activity and the 4G/5G polymorphism are prospectively associated with blood pressure and hypertension status
    Jacobs, Adriaan
    Schutte, Aletta E.
    Ricci, Cristian
    Pieters, Marlien
    JOURNAL OF HYPERTENSION, 2019, 37 (12) : 2361 - 2370
  • [48] Evaluation of Factor V G1691A, prothrombin G20210A, Factor XIII V34L, MTHFR A1298C, MTHFR C677T and PAI-1 4G/5G genotype frequencies of patients subjected to cardiovascular disease (CVD) panel in south-east region of Turkey
    Serdar Oztuzcu
    Sercan Ergun
    Mustafa Ulaşlı
    Gülper Nacarkahya
    Yusuf Ziya Iğci
    Mehri Iğci
    Recep Bayraktar
    Ali Tamer
    Ecir Ali Çakmak
    Ahmet Arslan
    Molecular Biology Reports, 2014, 41 : 3671 - 3676
  • [49] Evaluation of Factor V G1691A, prothrombin G20210A, Factor XIII V34L, MTHFR A1298C, MTHFR C677T and PAI-1 4G/5G genotype frequencies of patients subjected to cardiovascular disease (CVD) panel in south-east region of Turkey
    Oztuzcu, Serdar
    Ergun, Sercan
    Ulasli, Mustafa
    Nacarkahya, Gulper
    Igci, Yusuf Ziya
    Igci, Mehri
    Bayraktar, Recep
    Tamer, Ali
    Cakmak, Ecir Ali
    Arslan, Ahmet
    MOLECULAR BIOLOGY REPORTS, 2014, 41 (06) : 3671 - 3676
  • [50] Prognostic value of ACE I/D, AT1R A1166C, PAI-I 4G/5G and GPIIIa a1/a2 polymorphisms in myocardial infarction
    Martinez-Quintana, Efren
    Chirino, Ricardo
    Nieto-Lago, Vicente
    Perez-Jimenez, Patricia
    Lopez-Rios, Laura
    Rodriguez-Gonzalez, Fayna
    CARDIOLOGY JOURNAL, 2014, 21 (03) : 229 - 237